COVID-19 in children and the effect of schools reopening on potential transmission to household members.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
09 2021
Historique:
revised: 24 04 2021
received: 12 03 2021
accepted: 27 05 2021
pubmed: 31 5 2021
medline: 12 8 2021
entrez: 30 5 2021
Statut: ppublish

Résumé

The effect of reopening schools on children's contribution to SARS-CoV-2 transmission, especially within households, remains controversial. This study describes the clinical presentation of a large ambulatory COVID-19 paediatric cohort and evaluates the role of children in household transmission prior to and following school reopening. A retrospective database cohort study was conducted in a large Health Maintenance Organization in Israel. Data of all paediatric, laboratory-confirmed Coronavirus cases between 28/2/2020 and 20/6/2020 were extracted. All cases were analysed for household contacts and primary cases within each family cluster. A total of 1,032 cases under 18 years old (median age 12 years) were included. Of these cases, 432 (41.9%) were asymptomatic; 122 (11.8%) cases acquired the infection at school, and 45 of them were part of two school clusters; 846 children had at least one positive household contact, in 498 family clusters, and among them, 293 primary cases were identified. Only 27 (9.2%) primary cases were under 18 years of age and six (2%) were below 10. The proportion of primary cases did not change after the re-opening of educational facilities. Children, particularly under 10 years of age, are less likely to be the vector for SARS-CoV-2 infection within household settings. Opening educational facilities did not change transmission dynamics.

Identifiants

pubmed: 34053108
doi: 10.1111/apa.15962
pmc: PMC8222890
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2567-2573

Informations de copyright

©2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

World J Pediatr. 2020 Jun;16(3):267-270
pubmed: 32180140
JAMA Pediatr. 2021 Jan 1;175(1):73-80
pubmed: 32857112
Lancet Infect Dis. 2021 May;21(5):617-628
pubmed: 33476567
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Pediatr. 2021 Feb 1;175(2):198-201
pubmed: 32840605
Clin Infect Dis. 2021 Dec 16;73(12):2265-2275
pubmed: 33460434
Euro Surveill. 2020 Sep;25(36):
pubmed: 32914746
J Pediatr. 2020 Aug;223:14-19.e2
pubmed: 32407719
Pediatr Infect Dis J. 2020 Aug;39(8):e202-e204
pubmed: 32496407
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Pediatrics. 2020 Aug;146(2):
pubmed: 32457213
Am J Otolaryngol. 2020 Sep - Oct;41(5):102573
pubmed: 32531620
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):136-140
pubmed: 33507890
Lancet Child Adolesc Health. 2021 Apr;5(4):256-264
pubmed: 33571450
Clin Infect Dis. 2021 Jun 15;72(12):2215-2217
pubmed: 32710743
Nat Med. 2020 Nov;26(11):1714-1719
pubmed: 32943787
Acta Paediatr. 2021 Sep;110(9):2567-2573
pubmed: 34053108
Pediatrics. 2020 Oct;146(4):
pubmed: 32759379
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
Pediatrics. 2021 Apr;147(4):
pubmed: 33419869
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
Zhonghua Er Ke Za Zhi. 2020 Mar 2;58(3):179-182
pubmed: 32135586
Pediatr Infect Dis J. 2020 May;39(5):355-368
pubmed: 32310621
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1319-1323
pubmed: 32941418
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116

Auteurs

Shirley Shapiro Ben David (S)

Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Infectious disease unit, E. Wolfson Medical Center, Holon, Israel.

Daniella Rahamim-Cohen (D)

Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.

Diana Tasher (D)

Pediatric Infectious disease unit, E. Wolfson Medical center, Holon, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Adi Geva (A)

Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Joseph Azuri (J)

Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nachman Ash (N)

Health Division, Maccabi Healthcare Services, Tel Aviv, Israel.
Health Systems Management Department, Ariel University, Ariel, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH